The thing that makes CABHI different from most senior-care funding

A separate article on this site covers the New Horizons for Seniors Program — federal funding that, with rare exceptions, explicitly excludes for-profit companies. CABHI is the deliberate opposite case, and it’s worth knowing both exist for exactly this reason.

The Centre for Aging + Brain Health Innovation, powered by Baycrest and established in 2015, was built specifically to fund and support companies, researchers, and healthcare organizations developing aging and brain health innovations — then connect them with real care settings to actually test what they’ve built. Its two flagship programs, Ignite and Fuel, target different stages of company maturity, and mixing them up wastes an application.

Ignite: the earliest-stage option, and genuinely non-dilutive

Ignite provides $50,000 to $150,000 CAD, released as milestones are completed, and — importantly — this funding is non-dilutive for everyone who receives it. No equity changes hands.

Eligibility is split into two tracks:

  • Companies: must be incorporated in Canada (federally or provincially), not owned by a parent company, and led by an applicant with signing authority — typically the founder or CEO. Ignite specifically targets very early-stage companies: less than $1 million CAD raised to date, under $250,000 CAD in annual revenue, and a valuation that doesn’t exceed $6 million CAD. Pre-valuation companies are explicitly eligible.
  • Healthcare and research organizations: solutions roughly at Technology Readiness Level 2–6 — early-stage development through prototype demonstration, well before a finished product.

Beyond the funding itself, Ignite includes access to a learning and networking series featuring industry experts — useful, but modest compared to what the larger Fuel program offers.

Fuel: more money, more maturity required — and a real catch for companies

Fuel offers up to $500,000 CAD over a 12-month period, aimed at companies and organizations that have already outgrown Ignite’s eligibility bar. It has two separate tracks, and they work very differently.

Stream A (start-up companies): eligibility requires a company valuation of at least $6 million CAD, or gross revenue over $250,000 CAD in the past 12 months — in other words, a company that has already cleared roughly where Ignite’s eligibility ends. This is the detail most worth reading carefully: Fuel’s company funding is dilutive. Recipients sign both a Fuel Funding Agreement and a separate Warrant Agreement — a legal document giving CABHI the right to buy equity in the company later, at agreed terms. In plain terms: unlike Ignite, this money isn’t free of strings — CABHI ends up with a real claim on a piece of the company. That’s a materially different deal than Ignite, and it’s easy to miss if you’re comparing the two programs purely by dollar amount.

Stream B (healthcare and research organizations): funding stays non-dilutive — there’s no equity to take from a hospital, care home, or research institute. Eligibility requires the technology be at a more advanced Technology Readiness Level (3–8), that at least $500,000 has already gone toward developing the specific technology, and that the organization dedicate at least one full-time-equivalent staff member to the project.

What Fuel and Ignite both actually provide beyond the cheque

CABHI calls this bundle Acceleration Services, and it’s genuinely substantial for a program of this size:

  • Access to more than 100 real care delivery organizations for testing and end-user feedback
  • Up to $5,000 toward external business consulting
  • Up to $10,000 toward scientific or research validation services
  • Mentorship from a network of more than 100 scientists and industry professionals
  • Partial subsidies for hiring interns
  • Discounted legal, regulatory, and financing services

For an early-stage company, the access to real testing sites is often worth more than the funding amount itself — validating a product with actual care organizations is exactly the step many age-tech companies struggle to reach on their own.

Does this funding actually lead anywhere? A real track record

CABHI’s own reporting gives a genuine, checkable answer. Since its 2015 launch — backed by $124 million CAD in initial funding, including $44 million from the federal government and $34.1 million from the Government of Ontario — CABHI has made 95 investments in companies and researchers. More than half of CABHI-funded companies have gone on to secure follow-on investment totalling over $529 million. That’s a meaningful signal: CABHI funding appears to function as validation that helps companies raise larger private investment afterward, rather than being an endpoint on its own.

Recent funding rounds give a sense of current scale and focus: a July 2026 round awarded $3.2 million across 25 Canadian companies and researchers working on AI and related technology for aging and brain health, including Ontario-based companies working on tools like remote cognitive monitoring during everyday phone conversations.

What this means in practice

For a company or startup: Ignite is the realistic entry point if you’re pre-revenue or very early-stage and want funding without giving up equity. Fuel is worth considering once you’ve cleared roughly the $6 million valuation or $250,000 revenue mark — but go in knowing Stream A is a dilutive deal, not free money, and weigh that against what your company would otherwise pay for that capital and equity elsewhere.

For a long-term care or retirement home: the Healthcare and Research Organization tracks in both programs are a genuine, non-dilutive path to funded technology pilots — and they come with something a small operator usually can’t access alone: a structured way to test a specific technology with real residents before committing to buy it.

What this article doesn’t settle

  • Both programs run on periodic application cycles, not a permanent open window. The specific dates and figures here reflect CABHI’s programs as published at the time of writing and will change — confirm current status directly on CABHI’s own site before applying, not from this summary.
  • This article doesn’t evaluate whether any specific CABHI-funded technology actually works — that’s a separate evidentiary question from whether the funding programs themselves are worth applying to.
  • Eligibility thresholds (valuation, revenue, TRL) are program rules, not guarantees of funding. Meeting the bar makes an application eligible for review, not automatically successful.
  • This is not financial or legal advice. The distinction between dilutive and non-dilutive funding described here is a real, important difference, but the exact terms of any specific agreement should be reviewed with your own legal and financial advisors before signing anything.